2-(2-mercaptocyclopentylthio)-4-methyl-N-(1-(methylamino)-1-oxo-3-phenylpropan-2-yl)pentanamide

ID: ALA4854379

PubChem CID: 85102817

Max Phase: Preclinical

Molecular Formula: C21H32N2O2S2

Molecular Weight: 408.63

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)SC1CCCC1S

Standard InChI:  InChI=1S/C21H32N2O2S2/c1-14(2)12-19(27-18-11-7-10-17(18)26)21(25)23-16(20(24)22-3)13-15-8-5-4-6-9-15/h4-6,8-9,14,16-19,26H,7,10-13H2,1-3H3,(H,22,24)(H,23,25)

Standard InChI Key:  BEYZFJSVCHWLPP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 28  0  0  0  0  0  0  0  0999 V2000
   28.5252  -12.4335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3502  -12.4335    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   28.0365  -11.7687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2519  -12.0237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2519  -12.8487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0365  -13.1035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2893  -10.9833    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   29.7627  -11.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5877  -11.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3502  -11.0044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7627  -10.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3502   -9.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5877  -10.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0002  -12.4335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0002  -11.0044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8252  -11.0044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2377  -10.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2377  -11.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0627  -10.2900    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.4753   -9.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8252   -9.5755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.0627  -11.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4722  -12.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2964  -12.4342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7098  -11.7192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2929  -11.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4700  -11.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  3  7  1  0
  2  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
  9 14  2  0
  9 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 17 19  1  0
 19 20  1  0
 17 21  2  0
 18 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END

Associated Targets(Human)

MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.63Molecular Weight (Monoisotopic): 408.1905AlogP: 3.46#Rotatable Bonds: 9
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.95CX Basic pKa: CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -0.21

References

1. Ayoup MS, Abu-Serie MM, Awad LF, Teleb M, Ragab HM, Amer A..  (2021)  Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.,  222  [PMID:34116327] [10.1016/j.ejmech.2021.113558]

Source